NKTR-102: Updated Phase II data

Updated data from an open-label Phase II trial in 66 evaluable patients who failed a prior taxane-based

Read the full 174 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE